Skip to content

Biostar Pharmaceuticals, Inc.

CIK 0001418133

← back to feed
Revenue (TTM)
$644.93K
−91.2% YoY Q3 Nov 2017
Net Income (TTM)
−$4.02M
+77.3% YoY Q3 Nov 2017
EPS Diluted (TTM)
−$1.64
+78.1% YoY Q3 Nov 2017
Gross Margin
47.8%
Q3 Nov 2017
Operating Margin
-791.3%
Q3 Nov 2017
Net Margin
-622.9%
Q3 Nov 2017
Free Cash Flow (TTM)
$6.57M
Q3 Nov 2017
Cash
$364.97K
Q3 Nov 2017
Total Debt
$2.43M
Q3 Nov 2017
Shares Outstanding
2.64M sh
Q3 Nov 2017

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings